Showing 1 - 19 results of 19 for search 'Iams, S', query time: 0.04s
Refine Results
-
1
Carcinoid tumors outside the abdomen by Kenna Koehler, Wade T. Iams
Published 2023-04-01
Article -
2
Front Line Applications and Future Directions of Immunotherapy in Small-Cell Lung Cancer by Selina K. Wong, Wade T. Iams
Published 2021-01-01
Article -
3
-
4
Transnational voting rights and policies in violent democracies: a global comparison by Benjamin Nyblade, Elizabeth Iams Wellman, Nathan Allen
Published 2022-07-01
Article -
5
-
6
-
7
-
8
The frequency and extent of sub-ice phytoplankton blooms in the Arctic Ocean by Horvat, C, Jones, D, Iams, S, Schroeder, D, Flocco, D, Feltham, D
Published 2017Journal article -
9
-
10
The preterm birth syndrome: a prototype phenotypic classification. by Villar, J, Papageorghiou, A, Knight, H, Gravett, MG, Iams, J, Waller, SA, Kramer, M, Culhane, J, Barros, F, Conde-Agudelo, A, Bhutta, Z, Goldenberg, R
Published 2012Journal article -
11
Associations of influenza vaccination with severity of immune-related adverse events in patients with advanced thoracic cancers on immune checkpoint inhibitors by Emily Pei-Ying Lin, Li-Ching Huang, Jennifer Whisenant, Sally York, Travis Osterman, Jennifer Lewis, Wade Iams, Emily Skotte, Amanda Cass, Chih-Yuan Hsu, Yu Shyr, Leora Horn
Published 2022-10-01
Article -
12
692 COMMANDER-001: safety data from a phase I/II dose escalation/expansion study of SQZ-eAPC-HPV, a cell-based mRNA therapeutic cancer vaccine for HPV16+ solid tumors by Antonio Jimeno, Michael S Gordon, Howard Bernstein, Scott Loughhead, Jong Chul Park, Justin C Moser, Wade T Iams, Meredith Pelster, Kerry J Rodabaugh, Julia Jennings, Nathan Miselis, Marshelle S Warren, Victoria Villaflor, Melinda Morrison
Published 2023-11-01Article -
13
594 SQZ-PBMC-HPV-101: Increased overall survival in a subset of patients with recurrent, locally advanced, or metastatic HPV16+ tumors treated with cell-based vaccine, SQZ-PBMC-HPV... by Neesha Dhani, Antonio Jimeno, Michael S Gordon, Matthew H Taylor, Howard Bernstein, Scott Loughhead, Joaquina Baranda, Udo Holtick, Jong Chul Park, Wade T Iams, Monica MitaSc, Kerry J Rodabaugh, E Amanda Duvall, Julia Jennings, Nathan Miselis, Marshelle S Warren
Published 2023-11-01Article -
14
595 Biomarker results from the 1st line non-small cell lung cancer cohort of TACTI-002: pharmacodynamic effects of combining eftilagimod alpha (soluble LAG-3) and pembrolizumab by Enriqueta Felip, Christian Mueller, Martin Forster, Tim Clay, Matthew Krebs, Frederic Triebel, Enric Carcereny, Ewa Kalinka, Margarita Majem, Bernard Doger, Julio Peguero, Chrystelle Brignone, Igor Bondarenko, Wade T Iams, Manuel Cobo Dols, Grygorii Ursol, Gema Garcia Ledo, Laia Vilà Martinez
Published 2023-11-01Article -
15
748 Phase 1/2 study of the hexavalent OX40 agonist INBRX-106 alone and in combination with pembrolizumab in select solid tumors by Daniel Olson, Manish Sharma, Erminia Massarelli, Jonathan Thompson, Rachel E Sanborn, Ralph J Hauke, Anthony W Tolcher, Elizabeth Davis, Conor Steuer, Muhammad Furqan, John Hamm, Doug Laux, David Berz, Wade T Iams, Vasily Andrianov, Brianne O’Neill, Yaiza Diaz De Durana
Published 2023-11-01Article -
16
The distribution of clinical phenotypes of preterm birth syndrome: implications for prevention. by Barros, F, Papageorghiou, A, Victora, C, Noble, J, Pang, R, Iams, J, Cheikh Ismail, L, Goldenberg, R, Lambert, A, Kramer, MS, Carvalho, M, Conde-Agudelo, A, Jaffer, Y, Bertino, E, Gravett, MG, Altman, D, Ohuma, E, Purwar, M, Frederick, I, Bhutta, Z, Kennedy, S, Villar, J
Published 2015Journal article -
17
Better Estimation of Spontaneous Preterm Birth Prediction Performance through Improved Gestational Age Dating by Julja Burchard, George R. Saade, Kim A. Boggess, Glenn R. Markenson, Jay D. Iams, Dean V. Coonrod, Leonardo M. Pereira, Matthew K. Hoffman, Ashoka D. Polpitiya, Ryan Treacy, Angela C. Fox, Todd L. Randolph, Tracey C. Fleischer, Max T. Dufford, Thomas J. Garite, Gregory C. Critchfield, J. Jay Boniface, Paul E. Kearney
Published 2022-05-01
Article -
18
Making National Cancer Institute–Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study by Maitri Kalra, Elizabeth Henry, Kelly McCann, Meghan S Karuturi, Jean G Bustamante Alvarez, Amanda Parkes, Robert Wesolowski, Mei Wei, Sarah S Mougalian, Gregory Durm, Angel Qin, Caitlin Schonewolf, Meghna Trivedi, Avan J Armaghani, Frederick H Wilson, Wade T Iams, Anita A Turk, Praveen Vikas, Michael Cecchini, Sam Lubner, Priyadarshini Pathak, Kristen Spencer, Vadim S Koshkin, Matthew K Labriola, Catherine H Marshall, Katy E Beckermann, Marina N Sharifi, Anthony C Bejjani, Varsha Hotchandani, Samir Housri, Nadine Housri
Published 2022-05-01
Article -
19
The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC by Tejas Patil, MD, Alyse Staley, MS, Yunan Nie, MD, Mandy Sakamoto, MD, Margaret Stalker, MD, James M. Jurica, MD, MBA, Kenna Koehler, BA, Amanda Cass, PharmD, Halle Kuykendall, BA, Emily Schmitt, MS, Emma Filar, BA, Evelina Reventaite, MS, Kurt D. Davies, PhD, Hala Nijmeh, PhD, Mary Haag, PhD, Benjamin A. Yoder, PharmD, Paul A. Bunn, MD, Erin L. Schenk, MD, PhD, Dara L. Aisner, MD, PhD, Wade T. Iams, MD, Melina E. Marmarelis, MD, D. Ross Camidge, MD, PhD
Published 2024-02-01
Article